retatrutide lilly Eli 2023: Crossover appeal Eli Lilly Reports Strong Late-Stage

doi: 10.1186/s13054-025-05516-2 58

The Everything Guide to GLP-1s just for you

Previous studies show that GLP-1 receptor agonist treatment reduced microglial activation and reverse lipopolysaccharide (LPS)-induced inflammation in the hippocampus (36,88,89), indicating that these properties are preserved in its conjugated form

Kahkoska 1 TJA, G Caleb Alexander 3 4 5, Tellen D Bennett 6, Christopher G Chute 7, Melissa A Haendel 8, Klara R Klein 9, Hemalkumar Mehta 3 4, Joshua D Miller 10, Richard A Moffitt 11, Til Strmer 12, Kajsa Kvist 2, John B Buse, N3C consortium

The 2022 ASMBS/IFSO guidelines support consideration of metabolic surgery for patients with BMI 35 kg/m or 30 kg/m with obesity-related comorbidities